Here’s what you should know:
1. Mr. Davis has 30-plus years of executive experience across the U.S., Europe and Japan.
2. He notably served Johnson & Johnson for 27 years, eventually becoming president of J&J Development. He most recently served on Cleveland Clinic’s Innovations Advisory Board.
3. Clinical Genomics CEO Lawrence LaPointe, PhD, said, “We are pleased to welcome Roy as our newest Board Member. He brings a deep understanding of healthcare and commercial expertise to our team. We are very fortunate to have him by our side as we continue to carry out our mission. Roy will be an asset to our Board of Directors, and provide valuable counsel to the organization.”
More articles on supply chain:
8 trends in pharmaceutical sales — 95.7% still through distributors
Microbot Medical names former Codman Neurosurgery president to board: 4 key points
Medline, ROi enter into strategic agreement: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.